The second phase of myeloma treatment is called a Stem Cell Transplant. In this case, doctors use an “Autologous” Stem Cell Transplant, meaning cells are taken from the patient. This occurs after the patient has had a high dose of chemotherapy. The stem cell transplant, according to Dr. Nina Shah, hematologist from UCSF, “allows us an opportunity to give you a very high dose of chemotherapy, so that we can really get out that hard-to-reach myeloma.”
Generally in the United States, the high dose chemotherapy doctors use is called melphalan, which is a very traditional chemotherapy used to kill cancer cells, and works well for multiple myeloma. This high dose of chemotherapy isn’t just going to kill the bad cells. It’s also going to kill the good cells, particularly those in the bone marrow that help produce red cells, normal white cells and platelets.
Read MoreLearn more about SurvivorNet's rigorous medical review process.